The press release below was prepared by the American Association for Cancer Research. View the original here. Next-generation sequencing for minimal residual disease was highly sensitive and more ...

Phase IIa trial of chimeric antigen receptor modified T cells directed against CD19 (CTL019) in patients with relapsed or refractory CD19+ lymphomas. Combination of everolimus with R-CHOP (ever R-CHOP ...

Flow cytometry is a way to look closely at the features of cells or particles. A sample of blood or tissue goes into a machine called a cytometer. In less than a minute, a computer can analyze ...

In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months ...

Cancer immunotherapy is increasingly being evaluated as an approach to cancer treatment by harnessing the immune system to attack cancer cells. Both the adaptive and innate arms of the immune system ...

The mechanisms of resistance to immunotherapies in patients with acute myeloid leukemia (AML) are not well-characterized, and biomarkers for improved immunotherapeutic strategies are critical. In this ...